- DocumentoThe BCL2 E17 and SP66 antibodies discriminate 2 immunophenotypically and genetically distinct subgroups of conventionally BCL2caricato daivanlch
- DocumentoTrombosis en MM 2020caricato daivanlch
- DocumentoGuias ASH cancer y trombosis 2021 (1)caricato daivanlch
- DocumentoCómo evalúo y manejo el riesgo de hemorragia en pacientes tratados por tromboembolismo venosocaricato daivanlch
- DocumentoTrasplante de células progenitoras hematopoyéticascaricato daivanlch
- DocumentoTargeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemiacaricato daivanlch
- DocumentoBortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA) a randomised, open-label, phase 3 studycaricato daivanlch
- Documentobenefits.pdfcaricato daivanlch
- DocumentoBortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplant in multiple myeloma.pdfcaricato daivanlch
- DocumentoApproach to the patient with neutropenia in childhood.pdfcaricato daivanlch
- DocumentoAcute basophilic leukemia associated with the FUS-ERG fusion gene.pdfcaricato daivanlch
- DocumentoAnemia sideroblástica..pdfcaricato daivanlch
- DocumentoBortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplant in multiple myeloma.pdfcaricato daivanlch
- Documentobenefits.pdfcaricato daivanlch
- DocumentoAnemia sideroblástica..pdfcaricato daivanlch
- DocumentoApproach to the patient with neutropenia in childhood.pdfcaricato daivanlch
- DocumentoAcute basophilic leukemia associated with the FUS-ERG fusion gene.pdfcaricato daivanlch
- DocumentoTransfusion Practices ed6 Harmening.pdfcaricato daivanlch
- DocumentoModern Blood Banking & Transfusion Practices ed6 Harmening-235-257.pdfcaricato daivanlch
- DocumentoModern Blood Banking & Transfusion Practices Ed6 Harmening-235-257caricato daivanlch